Can Carfate (ursodeoxycholic acid) be co‑administered with Pepcid (famotidine) without dose adjustment or significant drug interaction?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 28, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Carafate and Pepcid Be Co-Administered?

Yes, Carafate (sucralfate) and Pepcid (famotidine) can be co-administered, but they should be separated by at least 2 hours to avoid reduced absorption of famotidine.

Key Drug Interaction Considerations

Famotidine Has Minimal Drug Interactions

Famotidine demonstrates a notable lack of drug interactions compared to other H2-receptor antagonists. Studies show that famotidine has negligible interaction with the cytochrome P450 system and does not affect the pharmacokinetics of commonly co-administered drugs 1. The FDA label confirms that "no drug interactions have been identified" and that famotidine shows "no significant interference with the disposition of compounds metabolized by the hepatic microsomal enzymes" 2.

Sucralfate's Absorption-Based Interactions

The critical issue is that sucralfate can impair the absorption of orally administered drugs because it remains unabsorbed in the GIT for considerable time, forming a mucosal barrier 3. While the evidence specifically documents sucralfate reducing absorption of fluoroquinolones, NSAIDs, and other H2-blockers, the mechanism applies broadly to oral medications 3.

Practical Administration Strategy

Separate the doses by at least 2 hours:

  • Give famotidine first (on empty stomach if possible for optimal absorption)
  • Wait 2 hours minimum
  • Then administer sucralfate (typically given 1 hour before meals and at bedtime)

This timing strategy prevents the physical barrier created by sucralfate from interfering with famotidine absorption while maintaining the therapeutic efficacy of both agents.

Important Caveats

  • No dose adjustment is required for either medication when co-administered with proper timing separation 2, 3
  • Monitor for reduced famotidine efficacy (breakthrough acid symptoms) if timing separation is inadequate
  • In patients with renal insufficiency (creatinine clearance <50 mL/min), famotidine dosing requires adjustment independent of sucralfate co-administration 2
  • Antacids may also be given concomitantly with famotidine if needed, per FDA labeling 2

References

Research

Famotidine: a notable lack of drug interactions.

Scandinavian journal of gastroenterology. Supplement, 1987

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.